<SEC-DOCUMENT>0000950170-24-123274.txt : 20241107
<SEC-HEADER>0000950170-24-123274.hdr.sgml : 20241107
<ACCEPTANCE-DATETIME>20241107160514
ACCESSION NUMBER:		0000950170-24-123274
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20241107
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241107
DATE AS OF CHANGE:		20241107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Boundless Bio, Inc.
		CENTRAL INDEX KEY:			0001782303
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				830751369
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41989
		FILM NUMBER:		241435493

	BUSINESS ADDRESS:	
		STREET 1:		9880 CAMPUS POINT DRIVE
		STREET 2:		SUITE 120
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 766-9912

	MAIL ADDRESS:	
		STREET 1:		9880 CAMPUS POINT DRIVE
		STREET 2:		SUITE 120
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bold-20241107.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-11-07T09:18:52.0793+00:00 -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:bold="http://boundlessbio.com/20241107" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;line-height: 1;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_17934b4a-297a-46e1-b28f-67b3120047c7" name="dei:AmendmentFlag" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f">false</ix:nonNumeric><ix:nonNumeric id="F_b4545005-fe6d-4c7f-ab22-3c37302bf467" name="dei:EntityCentralIndexKey" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f">0001782303</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="bold-20241107.xsd"/></ix:references><ix:resources><xbrli:context id="C_396aec80-7787-42fe-be5e-88a09ff4501f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001782303</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-07</xbrli:startDate><xbrli:endDate>2024-11-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e1bafd4-1779-4b19-ba43-5c97f6998519" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_834e6526-9acc-4247-a291-76d1610c57fa" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">November 07, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1171a9da-5f12-4aaf-8ab6-1416280ef9e9" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact Name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:18%;box-sizing:content-box;"/>
    <td style="width:41%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d0a63a9e-efae-4d5a-bd18-b796c0a0f173" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7f0c3dea-c96f-4eb2-a495-9071064adc52" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-41989</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d33d1d49-e0eb-41cf-bed4-8b5382394814" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">83-0751369</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_662eb7ba-0bb3-486d-a230-89f60b3ba65e" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">9880 Campus Point Drive, Suite 120,</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f672f644-9146-4dc0-bd72-156d667161a3" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">San Diego</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_adcc1189-c399-4b4a-923d-e9959e0b877e" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2a3fde9a-2d2f-4ae1-b37f-594d8de82d1b" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">92121</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_91ed625e-b80d-44dc-98b5-deca96313400" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(858)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_d199d898-3629-442b-9bd3-9a31eb8d09a8" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">766-9912</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f8a435a7-59f3-49f1-a92e-df5605fae124" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">N/A</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_12b0fcba-4b24-4881-9969-df482922e8dc" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cebeab6d-0697-42c9-9fb5-6c4ba66084e0" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3040f694-bc14-4906-996f-260d400081c0" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c5f047a8-3dd7-4ed3-b6f8-c9afbfe229b3" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_8d9d447d-d66f-4f1e-8ef2-202fbdf5900d" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_df4205e3-1e20-485a-bc50-30560a1bfc27" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">BOLD</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2f71119c-4065-4b1c-88ac-760abac28022" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_99f59c69-3fb8-4967-b9ed-28095c30390a" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_687dfedc-69c1-4423-9b18-f07f3fde640f" contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 7, 2024, Boundless Bio, Inc. (the Company) issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation by reference language in any such filing, unless the Company specifically states in such filing that such information, or a portion thereof, is to be considered &#8220;filed&#8221; rather than furnished or incorporated by reference therein.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.08%;box-sizing:content-box;"/>
    <td style="width:2.02%;box-sizing:content-box;"/>
    <td style="width:90.9%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="bold-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release Issued on November 7, 2024</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:44%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:46%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">BOUNDLESS BIO, INC.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">November 7, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Jessica Oien</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name: Jessica Oien<br/>Title: Chief Legal Officer and Corporate Secretary</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bold-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;line-height: 1;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img6362560_0.jpg" alt="img6362560_0.jpg" style="width:255px;height:38px;"></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:13pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:13pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:13pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Enrollment progressing in BBI-355 POTENTIATE and BBI-825 STARMAP clinical trials, with initial proof-of-concept data expected in the second half of 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash position of $167 million, with operating runway into the fourth quarter of 2026</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SAN DIEGO, November 7, 2024</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x2013; </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio</font></font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> (Nasdaq: BOLD)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today provided business updates and reported financial results for the third quarter of 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;The third quarter was marked by steady execution across the portfolio, with the POTENTIATE and STARMAP trials continuing to enroll patients,&#x201d;</font><font style="color:#2b5152;white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">said Zachary Hornby, President and Chief Executive Officer of Boundless Bio. &#34;In September, together with our development partner, SOPHiA GENETICS, we presented analytical validation for our proprietary ecDNA diagnostic, ECHO, a critical first step in identifying ecDNA positive patients for our clinical programs. We are capitalized to advance our lead programs through proof-of-concept data and remain focused on delivering impactful results for our patients and stakeholders.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Program Highlights and Upcoming Milestones</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">BBI-355, a novel, oral, potent, selective CHK1 inhibitor targeting replication stress for cancer patients with driver oncogene amplifications</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Enrollment is proceeding in the Phase 1/2 POTENTIATE clinical trial evaluating BBI-355 as a single agent and in combination with targeted therapies in patients with oncogene amplified solid tumors.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No new safety signals have been observed. </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The company anticipates reporting initial clinical proof-of-concept data in the second half of 2025.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">BBI-825, a novel, oral, potent, selective RNR inhibitor targeting ecDNA assembly and repair for cancer patients with resistance oncogene amplifications</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Enrollment continues to progress in the single agent, dose-escalation portion of the STARMAP clinical trial, with initial clinical proof-of-concept data expected in the second half of 2025.</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ecDTx 3, a novel kinesin program involved in ecDNA segregation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The company&#x2019;s third ecDTx program, directed to a previously undrugged kinesin target essential for ecDNA segregation whose inhibition is synthetic lethal to ecDNA-enabled cancer cells, continues to advance through lead optimization.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ECHO, a proprietary diagnostic for detection of ecDNA amplified oncogenes</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In September, analytical validation data was presented at the European Society for Medical Oncology (ESMO) Congress for the company&#x2019;s proprietary ecDNA diagnostic ECHO (ecDNA Harboring Oncogenes). ECHO is currently being used as a clinical trial assay to determine ecDNA status of patients enrolled in the BBI-355 POTENTIATE trial.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Third Quarter 2024 Financial Results</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Cash Position:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Cash, cash equivalents, and short-term investments totaled $167.1 million as of September 30, 2024.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">R&amp;D Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Research and development (R&amp;D) expenses were $14.1 million for the third quarter of 2024 compared to $11.6 million for the same period in 2023.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">G&amp;A Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> General and administrative (G&amp;A) expenses were $4.6 million for the third quarter of 2024 compared to $3.3 million for the same period in 2023.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Net Loss:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Net loss totaled $16.5 million for the third quarter of 2024 compared to $13.2 million for the same period in 2023.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">About BBI-355</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio&#x2019;s lead ecDNA-directed therapy (ecDTx), BBI-355, is a novel, oral, selective small molecule inhibitor of checkpoint kinase 1 (CHK1) being studied in the ongoing, first-in-human, Phase 1/2 POTENTIATE clinical trial (</font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NCT05827614</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) in cancer patients with oncogene amplifications. CHK1 is a master regulator of cells&#x2019; response to replication stress (RS). RS is elevated in cancer cells with oncogene amplification, including on ecDNA, and, because of this, represents a key vulnerability of those cells. BBI-355 was designed to exploit the elevated RS in ecDNA-enabled oncogene amplified cancer cells by disrupting proper CHK1 function in regulating RS and thereby facilitating catastrophic RS to preferentially kill cancer cells relative to healthy cells.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">About BBI-825</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio&#x2019;s second ecDTx, BBI-825, is a novel, oral, selective small molecule inhibitor of ribonucleotide reductase (RNR) being studied in the ongoing, first-in-human, Phase 1/2 STARMAP clinical trial (</font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NCT06299761</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) in colorectal cancer patients with </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">BRAF</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">V600E</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">KRAS</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">G12C</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> mutations and resistance gene amplifications. In preclinical studies, BBI-825 demonstrated low double digit nanomolar RNR inhibition and tumor growth inhibition, including regressions, in both the prevention and treatment of amplification-mediated resistance in mitogen-activated protein kinase (MAPK) pathway-activated tumors. RNR is the rate-limiting enzyme responsible for cellular </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">de novo</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> synthesis of deoxynucleotide triphosphates (dNTPs), the building blocks of DNA, and is essential to the assembly and repair of ecDNA. BBI-825 was shown to dysregulate ecDNA-reliant cancer cell dNTP pools, deplete ecDNA, and was synthetic lethal in multiple oncogene amplified preclinical cancer models.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">About Boundless Bio</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics to address the significant unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Boundless Bio is developing the first ecDNA-directed therapy (ecDTx), BBI-355, which is an oral inhibitor of checkpoint kinase 1 (CHK1) being evaluated in a Phase 1/2 clinical trial in cancer patients with oncogene amplifications. Boundless Bio&#x2019;s second ecDTx, BBI-825, is an oral inhibitor of ribonucleotide reductase (RNR) being evaluated in a Phase 1/2 clinical trial in colorectal cancer patients with </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">BRAF</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">V600E</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">KRAS</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">G12C</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> mutations and resistance gene amplifications. Leveraging its Spyglass platform, Boundless Bio has an additional program (ecDTx 3) advancing through preclinical development and discovery. Boundless Bio is headquartered in San Diego, CA.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">For more information, visit </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">www.boundlessbio.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. Follow us on </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">LinkedIn</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">X</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Boundless Bio cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. The forward-looking statements are based on our current beliefs and expectations and include but are not limited to: the potential to achieve catalysts and long-term patient impact; the timing of expected data readouts; the sufficiency of our cash position to fund operations through initial clinical proof-of-concept data readouts and into the fourth quarter of 2026; the potential safety and therapeutic benefits of our ecDTx in treating patients with oncogene amplified cancers; the potential clinical validity and utility of our ecDNA diagnostic ECHO; and the potential for one or more of our ecDTx, if approved, to be the first ecDNA-directed therapy. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in our business, including, without limitation: we are early in our development efforts and our approach to discover and develop ecDTx directed against ecDNA in oncogene amplified cancers is novel and unproven; results from preclinical studies or early clinical trials not necessarily being predictive of future results; analytical validation of an ecDNA diagnostic not necessarily being predictive of its clinical validity and utility; potential delays in the commencement, enrollment, data readouts or completion of clinical trials or preclinical studies; our dependence on third parties in connection with clinical trials, preclinical studies, ecDNA diagnostic development, and manufacturing; unfavorable results from clinical trials or preclinical studies; we may expend our limited resources to pursue a particular ecDTx and fail to capitalize on ecDTx with greater development or commercial potential; unexpected adverse side effects or inadequate efficacy of our ecDTx that may limit their development, regulatory approval, and/or commercialization; the potential for our programs and prospects to be negatively impacted by developments relating to our competitors, including the results of studies or regulatory determinations relating to our competitors; regulatory developments in the United States and foreign countries; efforts to streamline operations may not produce the efficiencies expected; we may use our capital resources sooner than we expect; and other risks described in our filings with the Securities and Exchange Commission (SEC), including under the heading &#x201c;Risk Factors&#x201d; in our quarterly report on Form 10-Q for the quarter</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ended March 31, 2024 and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Investor Contacts:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Ben Flaum, Boundless Bio</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">bflaum@boundlessbio.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Renee Leck, THRUST Strategic Communications </font><font style="color:#444444;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">renee@thrustsc.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.77%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.898%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.06%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.898%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:2.519%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.898%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.06%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.898%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:14pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="15" style="vertical-align:bottom;"><p style="font-size:14pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">BOUNDLESS BIO, INC.</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:14pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="15" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Condensed Financial Information</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="15" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Unaudited)</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Condensed Statements of Operations Data:</font></p></td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended<br>September 30</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Nine Months Ended<br>September 30</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:5pt;vertical-align:bottom;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(In thousands, except per share amounts)</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating expenses:</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,089</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,645</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,953</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32,223</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">General and administrative</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,626</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,308</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,036</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,777</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,715</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,953</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,989</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(18,715</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(14,953</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(54,989</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(41,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other income, net:</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest income</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,174</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,748</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,977</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,662</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other income, net</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">97</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">48</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total other income, net</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,206</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,780</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,074</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,710</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(16,509</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(13,173</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(48,915</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(37,290</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss per share, basic and diluted</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(0.74</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(10.71</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(3.22</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(30.89</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares used in calculation</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,254</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,230</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,204</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,207</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Condensed Balance Sheet Data:</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">September 30,</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:5pt;vertical-align:bottom;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(In thousands)</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash, cash equivalents, and short-term investments</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">167,135</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">120,752</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,093</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">129,894</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total liabilities</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,010</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,359</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Convertible preferred stock</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">247,617</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accumulated deficit</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(185,024</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(136,109</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total stockholders' equity (deficit)</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">165,083</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(127,082</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Working capital (1)</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">160,439</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">114,845</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;&#160;__________</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(1) We define working capital as current assets less current liabilities.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img6362560_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img6362560_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #=!;@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8^Z>M=E6/X8T?^Q="AMG&)V_>S?[YZCJ1P !QUQGO6M)(D4;22.J(@+,S'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK[_OVG_Q5>745R?VA6/5_L'!]G]YZC_PLC1_^?:^_P"_:?\ Q5'_  LC1_\
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MWTN22+^%I)@C'Z@ X_.O.J*\R>859?#H?2T<@PL%^\O)_=^1Z#_PL[_J$?\
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M_P *WT?_ )^;[_OXG_Q-9_[;Y'1_PC_W@_X61H__ #[7W_?M/_BJ/^%D:/\
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M:AEDD_:3ZZ:_@9_Q+O<6]C8JT9W.TSC/S# POX'<WY>U2>#O!WV3R]3U./\
MTC[T,##_ %?HS#^]Z#M]>G0-H4=UXC.K7@CD,*+':Q@<*!R6;/5MQ..P&#UZ
M;%:QPW-6=6?R.6>8NGA(X6C_ -O/UZ?HPK!\3>)H/#]K@;9;V0?NH<]/]IO;
M^?3U(/$WB:#P_:X&V6]D'[J'/3_:;V_GT]2/(KN[GOKJ2YN96EFD.6=N_P#G
MTJ,7B_9^Y#?\C?*<I>(?M:OP?G_P#V'PE=SWWAJUN;F5I9I#(6=N_P"\;_.*
MN:U&\NA:C'&C.[VTBJJC))*G  KG?AU?>?H4MHTFY[:4X7;C:C<CGO\ -O\
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M_P"1/O\ _MG_ .C%KQZO$S+^*O3]6?9\._[K+_$_R0445Z#\,?\ F*_]LO\
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M>X_V#H__ $";'_P'3_"C^P='_P"@38_^ Z?X4?V9/^8/]9*7\C/#J]!^&/\
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M4I*FNA]-P_@W3INO-:RV]/\ @A1117FGT05UWPYD1/$<JLZJ7MF503C<=RG
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M7_F_!!_8N!_D_%_YGO-A=?;M.MKO9L\^))=N<[=P!QGOUJQ6?H/_ "+NF?\
M7I%_Z *T*]Z#O%-GPU6*C4DET;"O#M>_Y&+4_P#K[E_]#->XUX=KW_(Q:G_U
M]R_^AFO.S/X(GT'#?\6?I^IGT445XY]<>H_\+(T?_GVOO^_:?_%4?\+(T?\
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M+2"QM8[:VB6*&,85%[?Y]:FHKNHT*=)>ZCQ<7CJ^*=ZKT[= HHHK8XPHHHH
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M.KZ!HKCQ.$]NT[VL>OEN:_4H2CR<U_.WZ,^?J*^@:*YO[,_O_A_P3TO]9?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% $-W:07UK);7,2RPR##(W?\
MSZUXUXAT*?0=3>"1&\AR3!(3G>F?7U'&1_0BO:ZIZII=KK%B]G>1[HVY!'WD
M/9@>Q_STKEQ6&5:.FZ/4RS,98.IKK%[K]4>%45H:QH]UHM]);W$4@0.1%*RX
M64#N.W0CC/&<5GUX$HN+L]S[N$XU(J<'=,VM \37OA^1A#MEMY""\+DX/N#V
M..,_F#@5ZGHWB#3]<AWVDN)!G=!)@2*!W(STY'(XY]:\2HKIP^,G1TW1YF/R
MBCBWS?#+O_FCZ!HKQZQ\:Z[8^6OVO[1&F?DN%#[LYZM]X]?7]*W(/B9,L*BX
MTN.27^)HYBBGZ @X_.O2AF%&6^A\[5R'%P?NI2]'_G8]%HKS_P#X6=_U"/\
MR9_^PK.OOB+JL_F+:0P6J-C:V-[KTSR>#W_A[_C52Q]!+1W^1$,CQLG9QMZM
M?I<Z7QCX5AU2WDU"W,<-[$FYV8A5E4#^(G@$#H3]#Q@CS33]2O-*NA<V4[0R
M@%=P .0>Q!X/XT[4=5O]6F$M]=23,/NACA5Z= .!T'2J=>3B*T9U.>FK'U6
MP=2A0]C7DI+M;;R\U\CU?1/'6FZC&D5ZZV=UCYM_$;'G.&[=.^.N.:ZJOGZM
M+3_$&K:6H6SOI8T ($9.Y!DY.%;('/?%==',6E:HKGEXOAZ,GS8>5O)[??\
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M;U/X#G)&5.G*I+EB=6(Q%/#TW4J.R0[P=X5DU6XCU"Z7;81/D!ESYQ!Z8/\
M#ZG\/7'JM-CC2*-8XT5$0!551@ #H *=7T&'H1HQY4?!8_'3QE7GEHELNP44
M45N<(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% %/5-+M=8L7L[R/=&W((^\A[,#V/\ GI7DFO\ AF]\/R*9MLMO
M(2$F0'!]B.QQSC\B<&O9Z;)&DL;1R(KHX*LK#((/4$5RXC"QK*^S[GIY?F=7
M!NRUB]U_D> 45WVN_#PJK3Z,[.<_\>TA'<G[K'TXX/H>3TKA9X)K69H;B*2*
M5?O)(I5AWY!KQ*M"=)VFC[3"XVABHWI2^77[B.BBBL3K"BBB@ HHHH ****
M"BBB@ HHHH **N:=I5_JTQBL;629A]XJ,*O7J3P.AZUZ3X;\$VVD[;J_$=Q?
M*^Y"I.R/'3 .,GODCCC'3)Z*&&G6>FW<\_&YE0PD??=Y=EO_ , YCPWX'GU6
M..\OW:WLW!*JO$C^A&1@#W/7'3!!KTVTM(+&UCMK:)8H8QA47M_GUJ:BO<H8
M>%%>[OW/B\;F%;&2O-Z=%T"BBBMSA"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-U;0=-UJ/;>V
MZLX&%E7AUZXP?;).#D9[5I45,HJ2M)7+IU)TY<T'9GFVL?#JYAS+I,WVA/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bold-20241107.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-11-07T09:18:52.5319+00:00 -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://boundlessbio.com/20241107" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:bold="http://boundlessbio.com/20241107" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bold-20241107.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45994455027296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 07, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  07,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Boundless Bio, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001782303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-0751369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9880 Campus Point Drive, Suite 120,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">766-9912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BOLD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M"^#_M1#Z>&)>$I3O>,;_ E!+ P04    " "F@&=9GZ ;\+$"  #B#   #0
M 'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$
M>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-
M^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZF
MTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,7
M8&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/
MQA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<
M45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,
M%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>
M]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M
M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJR
MY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VW
ML,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VL
MT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/
MAG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+
MV.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0
MIA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "F@&=9EXJ[
M',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6
M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV
M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O
M@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=
MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (
M *: 9UDZJJ+G0 $  #P"   /    >&PO=V]R:V)O;VLN>&ULC5%=:\,P#/PK
MQC]@2<M66&D&8]U'86QE'7UW8J41M:U@J^W67S\E(:RPESW).HG3W7EQHK@O
MB?;JR[N0"MTPM_,L2U4#WJ0K:B'(I*;H#4L;=UEJ(QB;&@#V+IOF^2SS!H.^
M6XQ<ZYA=-L10,5(0L .V"*?T.^]:=<2$)3KD[T+W;P=:>0SH\0RVT+E6J:'3
M"T4\4V#C-E4DYPH]&09;B(S5'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T
M'D&6A^[ ](2.(2X-PW.D0XMAU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y
M1G"=P) :;)-6P7@H]+BB[H-5CX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#
M\%&MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$
M%     @ IH!G620>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT
M8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]
M:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8V
MP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!
M4$L#!!0    ( *: 9UEED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=
M+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5
MA4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0
M]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K
M'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*
M&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=
M(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+N
MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ IH!G60=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "F
M@&=9>NED2^\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "F@&=9F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *: 9UDS.V,;
MH00  .\1   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "F@&=9GZ ;\+$"  #B#   #0
M@ 'E#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *: 9UF7BKL<P    !,"
M   +              "  <$/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *:
M9UDZJJ+G0 $  #P"   /              "  :H0  !X;"]W;W)K8F]O:RYX
M;6Q02P$"% ,4    " "F@&=9)!Z;HJT   #X 0  &@              @ $7
M$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "F@&=9
M99!YDAD!  #/ P  $P              @ '\$@  6T-O;G1E;G1?5'EP97-=
:+GAM;%!+!08     "0 ) #X"  !&%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bold-20241107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="bold-20241107.htm">bold-20241107.htm</File>
    <File>bold-20241107.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bold-20241107.htm": {
   "nsprefix": "bold",
   "nsuri": "http://boundlessbio.com/20241107",
   "dts": {
    "inline": {
     "local": [
      "bold-20241107.htm"
     ]
    },
    "schema": {
     "local": [
      "bold-20241107.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_396aec80-7787-42fe-be5e-88a09ff4501f",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bold-20241107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_396aec80-7787-42fe-be5e-88a09ff4501f",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bold-20241107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://boundlessbio.com/20241107/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-24-123274-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-123274-xbrl.zip
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M=A6@1ZA\KM8@33$%H;PG (]>&]<)Q_O1)JGR$".F4:2L-T^"BPE&H2#HU.F
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M7[,$OIV3BU^_[K)C%?4GNX?Q/$A_+)O$)I.D"7[L%Z[!4L*8S->,]W>K[@F
M9S_1&H8)J-\5^(Q-YK"[+#.;,2 :/$T2!.L.IDAD"B#F<6)0UB;A')>[=.?;
MSDFWMXT^B=X$U26&ZD6.!Q$*;R$*+YG/[,&+;YFGN,;T,1P(&+ X'/%'(D$K
MV,Q-E^HV4#JN(')B$$>8>&B1,E8Q1Z#$LR+5>G9:! $8\'2B;%BSYDWG-]-F
M(<G-:_GU_&]@%G<^LY/;D8B,,.L4'5 '@FM_8&4EGWF[DXYRUP;,<9CL1F@!
M K.7DY='#P4XVTD[1_>O]7IU_]Y[A@\% QF1RMHL\%:31(U$;6FB]K-EXH^%
M$+6?P0/0:-"#I/$ '@,&UNZ@STXZSGO"MC='9A:0->!#$C42M96*VIF(V1=E
MUBIB.(;0'@2Z,^^JK1=IJV:U\1H1(D]Z$SSICUV5Q%D492L.J4P=V+H+>MGX
MO]L]N-N]L/F]8QONNKS=]=@DC5^:V?REN[PE,P1@9$,%OR>AR*4P@1CZ ^%?
MC90$HJ]D9/.4V0ZF_.^F03(3)X&\"V^IJ \/]SUW9*N"6Y@)$.<ME.2\L_H3
MUV?'E[768>-@OSXY<KXVK-RUR=OSTL$>R &KIH<O<&V'W"!R:M%/0IXM'FXC
M91R#.64C>$D@F,XYF[%S?K%;9><7V!RPQC5/$W+R6U*/C09X+/+#Q":VJS0E
MP_K['G"*SQ/HV*8,2>-A]RXDC"._$F-VG81HB75E*..Q>PZWSVRGU4G,%&/)
M@< $8J<2P#(+E70AY<F0D8)H9EOMP3/8*5E=W#@Q.AG9?#T,)\-7=FY[2>3V
M3Z#-=&[Q$>@$;4:4-P$O][B/(W??P73 6D ; ^GC@S;#2O2$=ON%X1@D">1M
M:@#9GCX^/! \C ?CE'@Z7;712NQP[25PUJK$TDP_JZX\-DFU?:FVTK*KHL0/
MA8IE($"J@L2/4>_LG)^=OUQCS<]Q7)>ZVF\<'8&^*HBZPJY@97@X7W.]_?#<
MHXM4)?IT_O&G%X[G6FB[O9G*D4E 0>0&>5BM[=5R/_6EC?E_]FNUDS6Z;R!7
M15K"?YQ_O"C;$OY<;QRO<06'2>RLQ?3@P>1@P5R#\A03;,4$Z!Q6F@DT@_DU
MA.<P2 8(&JH;%J@$J]P$L@^&6,0C!<C,=?XLA-W$B=*#A*ROU8W-#,^^R]N-
M6KC*=- %?LQ A[EJ(9B1A>93UI06W.X:(>A/D5 9BD#:P>4HA9:&$JM:1!6.
M2L1^#U9>#/H@<VMV .#_L8OH-;CAX]QSZ?E'1Y&K9X+45T();=KC'=&?XZ'(
MS&N)LV'/=8#YEN!4%$E^0"F"6E5K9$>7 P=+@TL7"'4[SBELT*LC,/Q' WMT
M:R<XN_QFP(O%.>\F,K0\T@V5?V7?SAP,Z[%,TO'2(G+SCMMD.5#5"3NC1V$&
MZB:RV1QCDYKX:3Y'!<QRR?&XQ)VMSG!0;*04)N@%X$:)[&DW%MOB;)X?,F 2
MQG(TOQY47N+2KH8J$,6W_I=:()<2XY>Z.(=+/?)'R?%E2H[?-D=Z;MG$K7&G
MG;O\5!G$P*97ICGN281:%-4IMV?S1UQS,.&&N8"?BR6+!-18FG\>V#BA.R'8
MCZS)!70GT5" Y2<PS-9[NJB$,Z<PXI8[(/M(349,<-9*H0Y.0XCSPX^3*@)6
MV8)/"@/E$:OO?6<CH=.^:97=F\ TT<)6G,,:M+;BV,+A=5AG?V#7(;(!BV<&
MT=/J'F[P/!=YF(DX/#L^_/RPR[SQ+Q16>0X-%#2@H $%#38F:/ %L%/SOBVR
M 3)\,1KWT8YG8(/'6#K7FX'; ;= @_8=MG!7G3%%5M;<38\[.3C.ZB_>>4GY
MM#B;)B>-KV 0XSG(CI?9I(D%#IPNH._/4O25QXX_%MW%*O(&2T&,H9^4=AI?
M1FFA9HPJ74MP"=90P_OFYJ;:S7BP*U45#+"UQ^JK["<58K@.3Z=$:YB5+S*Z
M$L%IM/:9L'"Q>OK_M7;"">@VT0$&[+OA.JA\4<JZ<Q>@MVU2Z.QQHLV$_FEE
M#RZB,UK&*D'W+[8'\MQTV,/47$;9QJ]TQQ)MZH5 5P5/;FL;808- K:"<2U@
MJ>@(W$]X ;PA5XV:^YBXHFV<W\Y^F,[^77=5=CEX['O[.N;4VG+1ME*U.WT(
MWE0H1<\97JXP3LX2<ULE& V_&YG=B+!N?3NMMA[?A<+!K99@*]FDE'!LTHK"
MH<*X&A[ 21VOM$IUQ^5B2EMM&*/E66$>>Y13@R&EDMBXITR"-<7A9=\F[%@2
MIJY]@=Y[L#K912](0F;*+5@7*.LP)?W1ZV$Z,[2GU0:S+)TTD@&S&XD>&JGI
MD)V]B1R!6THV^^>I"$9Z>\-LAQ-:[ E8F?8-G68I36EW]T^G=K)1YEJS-<*A
MV\RTR0\7'/4>XR.\-D($6*X=J'HR:%%E'_TXR5T>,>28]-3KP13VM!JF&5=&
MQ-BWW:&;)R5!(K(=%BW-E5N:!"<$A2MVI44'-M<)6\ Q9[=:Y#;Z7'DH#-U9
MYG4WE&#]>.1IP;6]0N->Y7G1Z]F[UK!+_,Y. 3"XW;M)'8#\H9ET<2<SP?LP
MQ&R"; </+B[Z#:[LD*//SG74N2OACC,V9Z,4U\N-?^:^+"NID?!A'KB6DR/&
MT$0@75X+K' OB1,MLDXZ#QRKQBW/Z#XG+=(!,OZC?-K)L6 @0CZ>% 4#*Q86
MP;?HY:6GFMV_IT45=S[5$+?%TK'.3H32\R:NDZ[V2$2!<&7OTIQPO&\@K5@+
MX!"EY0RL<-Z[DVSNUO6]F<KQE-NS PV3(*@G>#2\ \O=X]=*V]M;IA9\45*
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M3M/3 IQ/E:Q5CQKIK6UI&[79?,TU*MH']^!/\0B/2@R/ CSD?6O+1N"]+6:
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MVGBK<W>$&H0:A!J;B1JUZIM=1+D9L$&I*2_BK-_M%(F@PH$4WA<NN&)88D3
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M @ /              "  34=  !B;VQD+65X.3E?,2YH=&U02P4&      ,
, P"[    ACL

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>bold-20241107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bold-20241107.xsd" xlink:type="simple"/>
    <context id="C_396aec80-7787-42fe-be5e-88a09ff4501f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001782303</identifier>
        </entity>
        <period>
            <startDate>2024-11-07</startDate>
            <endDate>2024-11-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_17934b4a-297a-46e1-b28f-67b3120047c7">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_b4545005-fe6d-4c7f-ab22-3c37302bf467">0001782303</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_1e1bafd4-1779-4b19-ba43-5c97f6998519">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_834e6526-9acc-4247-a291-76d1610c57fa">2024-11-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_1171a9da-5f12-4aaf-8ab6-1416280ef9e9">Boundless Bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_d0a63a9e-efae-4d5a-bd18-b796c0a0f173">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_7f0c3dea-c96f-4eb2-a495-9071064adc52">001-41989</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_d33d1d49-e0eb-41cf-bed4-8b5382394814">83-0751369</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_662eb7ba-0bb3-486d-a230-89f60b3ba65e">9880 Campus Point Drive, Suite 120,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_f672f644-9146-4dc0-bd72-156d667161a3">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_adcc1189-c399-4b4a-923d-e9959e0b877e">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_2a3fde9a-2d2f-4ae1-b37f-594d8de82d1b">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_91ed625e-b80d-44dc-98b5-deca96313400">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_d199d898-3629-442b-9bd3-9a31eb8d09a8">766-9912</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_f8a435a7-59f3-49f1-a92e-df5605fae124">N/A</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_12b0fcba-4b24-4881-9969-df482922e8dc">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_cebeab6d-0697-42c9-9fb5-6c4ba66084e0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_3040f694-bc14-4906-996f-260d400081c0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_c5f047a8-3dd7-4ed3-b6f8-c9afbfe229b3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_8d9d447d-d66f-4f1e-8ef2-202fbdf5900d">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_df4205e3-1e20-485a-bc50-30560a1bfc27">BOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_2f71119c-4065-4b1c-88ac-760abac28022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_99f59c69-3fb8-4967-b9ed-28095c30390a">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_396aec80-7787-42fe-be5e-88a09ff4501f"
      id="F_687dfedc-69c1-4423-9b18-f07f3fde640f">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
